Gambia vs Latvia: Access to anti-retroviral drugs, female
Gambia
55.0%
in 2024
Latvia
54.0%
in 2024
Gambia rank
111th
Latvia rank
114th
Access to anti-retroviral drugs, female over time
- Gambia
- Latvia
How they compare
Gambia currently reports 55.0% against 54.0% in Latvia, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Latvia ahead.
Gambia ranks 111th and Latvia ranks 114th of 141 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Gambia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 2.5% | 0.9% | Latvia |
| 2010s | 26.0% | 20.4% | 5.6% | Gambia |
| 2020s | 48.0% | 51.2% | 3.2% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Gambia or Latvia?
- Gambia, at 55.0% against 54.0% in Latvia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Gambia and Latvia?
- 1.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Latvia?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Latvia rank globally for access to anti-retroviral drugs, female?
- Gambia ranks 111th and Latvia ranks 114th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.